Distinct localization of the complement C5b-9 complex on Gram-positive bacteria

Cellular Microbiology

Volumn 15, Issue 12, 2013, Pages 1955-1968

  Berends, Evelien T M ^a   Dekkers, Johanna F ^a,b   Nijland, Reindert ^a   Kuipers, Annemarie ^a   Soppe, Jasper A ^a   van Strijp, Jos A G ^a   Rooijakkers, Suzan H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CELL MEMBRANE; COMPLEMENT ACTIVATION; GRAM POSITIVE BACTERIUM; IMMUNOBLOTTING; LACTOCOCCUS LACTIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS PYOGENES;

BINDING SITES; CELL WALL; COMPLEMENT C3B; COMPLEMENT MEMBRANE ATTACK COMPLEX; GRAM-POSITIVE BACTERIA; HUMANS; PEPTIDOGLYCAN; PROTEIN BINDING;

EID: 84887613151     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12170     Document Type: Article

References (54)

1. Akesson, P., Sjöholm, A.G., and Björck, L. (1996) Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 271: 1081-1088.
2. Bestebroer, J., Aerts, P.C., Rooijakkers, S.H.M., Pandey, M.K., Köhl, J., Van Strijp, J.A.G., and De Haas, C.J.C. (2010) Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell Microbiol 12: 1506-1516.
3. Bhakdi, S., and Tranum-Jensen, J. (1983) Molecular composition of the terminal membrane and fluid-phase C5b-9 complexes of rabbit complement. Absence of disulphide-bonded C9 dimers in the membrane complex. Biochem J 209: 753-761.
4. Bhakdi, S., Käflein, R., Halstensen, T.S., Hugo, F., Preissner, K.T., and Mollnes, T.E. (1988) Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. Clin Exp Immunol 74: 459-464.
5. Dobrina, A., Pausa, M., Fischetti, F., Bulla, R., Vecile, E., Ferrero, E., etal. (2002) Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood 99: 185-192.
6. Esser, A.F., and Sodetz, J.M. (1988) Membrane attack complex proteins C5b-6, C7, C8 and C9 of human complement. Methods Enzymol 162: 551-578.
7. Fernie-king, B.A., Seilly, D.J., Davies, A., and Lachmann, P.J. (2002) Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect Immun 70: 4908-4916.
8. Fernie-king, B.A., Seilly, D.J., and Lachmann, P.J. (2004) The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins. Immunology 111: 444-452.
9. Frank, M.M., Joiner, K., and Hammer, C. (1987) The function of antibody and complement in the lysis of bacteria. Rev Infect Dis 9 (Suppl. 5): S537-S545.
10. Fredslund, F., Laursen, N.S., Roversi, P., Jenner, L., Oliveira, C.L.P., Pedersen, J.S., etal. (2008) Structure of and influence of a tick complement inhibitor on human complement component 5. Nat Immunol 9: 753-760.
11. Frick, I.-M., Akesson, P., Rasmussen, M., Schmidtchen, A., and Björck, L. (2003) SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 278: 16561-16566.
12. Haas, P.-J., and Strijp, J.A. (2007) Anaphylatoxins their role in bacterial infection and inflammation. Immunol Res 37: 161-175.
13. Hadders, M.A., Bubeck, D., Roversi, P., Hakobyan, S., Forneris, F., Morgan, B.P., etal. (2012) Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. Cell Rep 1: 200-207.
14. Janssen, B.J.C., and Gros, P. (2007) Structural insights into the central complement component C3. Mol Immunol 44: 3-10.
15. Joiner, K., Brown, E., Hammer, C., Warren, K., and Frank, M. (1983) Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. J Immunol 130: 845-849.
16. Joiner, K.A., Brown, E.J., and Frank, M.M. (1984) Complement and bacteria: chemistry and biology in host defense. Annu Rev Immunol 2: 461-491.
17. Joisel, F., Leroux-Nicollet, I., Lebreton, J.P., and Fontaine, M. (1983) A hemolytic assay for clinical investigation of human C2. J Immunol Methods 59: 229-235.
18. Kashyap, D.R., Wang, M., Liu, L.-H., Boons, G.-J., Gupta, D., and Dziarski, R. (2011) Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems. Nat Med 17: 676-683.
19. Laarman, A.J., Bardoel, B.W., Ruyken, M., Fernie, J., Milder, F.J., Van Strijp, J.A.G., and Rooijakkers, S.H.M. (2012) Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways. J Immunol 188: 386-393.
20. Lachmann, P.J., and Thompson, R.A. (1970) Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor C56 and the participation of C8 and C9. J Exp Med 131: 643-657.
21. Langley, R., Wines, B., Willoughby, N., Proft, T., Fraser, J.D., and Basu, I. (2005) The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-FcaRI binding and serum killing of bacteria. J Immunol 174: 2926-2933.
22. Laursen, N.S., Gordon, N., Hermans, S., Lorenz, N., Jackson, N., Wines, B., etal. (2010) Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc Natl Acad Sci USA 107: 3681-3686.
23. Law, S.K.A., and Dodds, A.W. (1997) The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci 6: 263-274.
24. Leenhouts, C.J., Ramasamy, R., Steen, A., Kok, J., Buist, G., and Kuipers, O.P. (2006) Method to provide bacterial ghosts provided with antigens. US7067639 B2.
25. Martinez, R.J., and Carroll, S.F. (1980) Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme. Infect Immun 28: 735-745.
26. Meri, S., Morgan, B.P., Davies, A., Daniels, R.H., Olavesen, M.G., and Waldmann, H. (1990) Human protectin (CD59), an 18000-20000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71: 1-9.
27. Milis, L., Morris, C.A., Sheehan, M.C., Charlesworth, J.A., and Pussell, B.A. (1993) Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9. Clin Exp Immunol 92: 114-119.
28. Mollnes, T.E., Lea, T., Harboe, M., and Tschopp, J. (1985) Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol 22: 183-195.
29. Müller-Eberhard, H.J. (1985) The killer molecule of complement. J Invest Dermatol 85: 47-52.
30. Müller-Eberhard, H.J. (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57: 321-347.
31. Nordenfelt, P., Waldemarson, S., Linder, A., Mörgelin, M., Karlsson, C., Malmström, J., and Björck, L. (2012) Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med 209: 2367-2381.
32. Nunn, M.A., Sharma, A., Paesen, G.C., Adamson, S., Lissina, O., Willis, A.C., and Nuttall, P.A. (2005) Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata. J Immunol 174: 2084-2091.
33. Pence, M.A., Rooijakkers, S.H.M., Cogen, A.L., Cole, J.N., Hollands, A., Gallo, R.L., and Nizet, V. (2010) Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J Innate Immun 2: 587-595.
34. Pinkney, M., Beachey, E., and Kehoe, M. (1989) The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect Immun 57: 2553-2558.
35. Podack, E.R., and Tschopp, J. (1982a) Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci USA 79: 574-578.
36. Podack, E.R., and Tschopp, J. (1982b) Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation. J Biol Chem 257: 15204-15212.
37. Podack, E.R., Kolb, W.P., and Müller-Eberhard, H.J. (1977) The SC5b-7 complex: formation, isolation, properties, and subunit composition. J Immunol 119: 3-9.
38. Reynolds, B.L., and Rowley, D. (1969) Sensitization of complement resistant bacterial strains. Nature 221: 1259-1261.
39. Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J.D. (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
40. Rooijakkers, S.H.M., Ruyken, M., Roos, A., Daha, M.R., Presanis, J.S., Sim, R.B., etal. (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6: 920-927.
41. Rooijakkers, S.H.M., Rasmussen, S.L., McGillivray, S.M., Bartnikas, T.B., Mason, A.B., Friedlander, A.M., and Nizet, V. (2010) Human transferrin confers serum resistance against Bacillus anthracis. J Biol Chem 285: 27609-27613.
42. Rosado, C.J., Kondos, S., Bull, T.E., Kuiper, M.J., Law, R.H.P., Buckle, A.M., etal. (2008) The MACPF/CDC family of pore-forming toxins. Cell Microbiol 10: 1765-1774.
43. Shepard, L.A., Heuck, A.P., Hamman, B.D., Rossjohn, J., Parker, M.W., Ryan, K.R., etal. (1998) Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy. Biochemistry 37: 14563-14574.
44. Silhavy, T.J., Kahne, D., and Walker, S. (2010) The bacterial cell envelope. Cold Spring Harb Perspect Biol 2: a000414. doi:10.1101/cshperspect.a000414.
45. Skattum, L., Van Deuren, M., Van der Poll, T., and Truedsson, L. (2011) Complement deficiency states and associated infections. Mol Immunol 48: 1643-1655.
46. Steckel, E.W., Welbaum, B.E., and Sodetzs, J.M. (1983) Evidence of direct insertion of terminal complement proteins into cell membrane bilayers during cytolysis. J Biol Chem 258: 4318-4324.
47. Tedesco, B.F., Pausa, M., Nardon, E., Introna, M., Mantovani, A., and Dobrina, A. (1997) The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185: 1619-1627.
48. Tedesco, F., Rottini, G., and Patriarca, P. (1981) Modulating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4. J Immunol 127: 1910-1915.
49. Tschopp, J., Engel, A., and Podack, E.R. (1984) Molecular weight of poly (C9). J Biol Chem 259: 1922-1928.
50. Tschopp, J., Podack, E.R., and Müller-Eberhard, H.J. (1985) The membrane attack complex of complement C5b-8 complex as accelerator of C9 polymerization. J Immunol 134: 495-499.
51. Tschopp, J., Chonn, A., Hertig, S., and Frencht, L.E. (1993) Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8b, and the b domain of C9. J Immunol 151: 2159-2165.
52. Walker, B., and Bayley, H. (1995) Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification. J Biol Chem 270: 23065-23071.
53. Walport, M.J. (2001) Complement first of two parts. N Engl J Med 344: 1058-1066.
54. Yamamoto, K.-I., and Migata, S. (1983) Mechanisms for the spontaneous formation of covalently linked polymers of the terminal membranolytic complement protein (C9). J Biol Chem 258: 7887-7889.